Universal Technical Institute has been on fire lately. In the past six months alone, the company’s stock price has rocketed ...

Post the aforesaid allotment, the issued and paid-up share capital of the Company shall be increased from Rs 1,27,97,70,710 (12,79,77,071 equity shares of face value of Rs 10 each) to Rs ...

UTI ENERGY, INC. (NASDAQ:PTEN) today reported that for the month of March 2025, the Company had an average of 106 drilling rigs operating in the United States. For the three months ended ...

Blujepa, the first new oral UTI antibiotic in 30 years, offers hope against antibiotic-resistant infections, improving ...

If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...

An uncomplicated urinary tracti infection (UTI) could go away on its own, but waiting increases the risk of symptoms turning ...

Sysmex’s PA-100 AST System is redefining the standard of care for diagnosing and treating uncomplicated urinary tract ...

A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...

This antibiotic is the first new FDA-approved medication for urinary tract infections in decades, and meets the need for new ...

The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...

Gepotidacin is an oral, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by blocking 2 different type II topoisomerase enzymes.

Blujepa, which is made by the British pharmaceutical company GSK plc, is approved for the treatment of women and children ...